Therefore, the CETP gene variants added to the intrinsic factors of hemolytic anemia itself (cumulative effect of chronic hemolysis, oxidative stress, and inflammation) could explain part of the variation observed in dyslipidemia in patients with SCD. The gene discussed is CETP; the disease is metabolic syndrome.